Popular Articles

Study Finds Estrogen Receptor-Negative Tumors Have Vaccine Targets
A comprehensive analysis of nearly 1,600 tumor samples has found that CT-X genes are expressed in nearly half the breast cancers that lack the estrogen receptor (ER). CT-X gene products are the targets of therapeutic cancer vaccines already in phase III clinical trials for lung cancer and melanoma. The study - to be published in the Early Edition of the Proceedings of the National Academy of Sciences this week - was led by the international Ludwig Institute for Cancer Research (LICR).

Billions Lost In Productivity Due To Vision Impairment
Corrected vision impairment could prevent billions of dollars in lost productivity annually, according to a study by researchers from the Johns Hopkins Bloomberg School of School of Public Health, the International Centre for Eyecare Education, the University of New South Wales and the African Vision Research Institute. Researchers estimate that nearly 158 million people globally suffer with vision impairment resulting from uncorrected refractive error, which can usually be eliminated with a pair of eyeglasses and an eye examination. This is the first study to estimate the productivity loss from uncorrected refractive error and is published in the June 2009 issue of the Bulletin of the World Health Organization.
News of the day
Two Pfizer Medicines Recommended For Use In NHS Wales
The All Wales Medicine Strategy Group (AWMSG) has today recommended two Pfizer medicines, Celsentri® (maraviroc) and Ecalta® (anidulafungin) for use in NHS Wales.1
Oncology

Operating Department Practitioner Struck Off For Failure To Report Drug Misuse

Operating Department Practitioner, Mr Mark McFarlane has been struck off the HPC Register after he failed to report the misuse of drugs by a colleague. The HPC Conduct and Competence Committee heard that Mr McFarlane knew a colleague was removing drugs for their own personal use and did not report that fact to his employer or the HPC. Standard four of the HPC standards of conduct, performance and ethics requires the disclosure of important information about other registrants and Mr McFarlane failed in his duty to report the matter to the HPC. HPC Panel Chair, Mr Raymond Pattison commented: "There was clearly potential for the drug usage to compromise patient safety and Mr McFarlane"s failure to disclose his colleague"s behaviour represented a very serious misjudgement." The Panel determined that Mr McFarlane"s fitness to practise was impaired by reason of misconduct and decided to strike Mr McFarlane from the Register. "Mr McFarlane"s default was serious and requires the imposition of a sanction. "The Panel is satisfied that a striking-off order is a proportionate response to the allegation because the failure to engage in the HPC process itself demonstrates a lack of insight into the shortcomings underpinning the allegation." Mr McFarlane was neither present nor represented at the hearing. Health Professions Council


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):